GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » PB Ratio

Dali Pharmaceutical Co (SHSE:603963) PB Ratio : 2.38 (As of May. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-28), Dali Pharmaceutical Co's share price is ¥4.07. Dali Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥1.71. Hence, Dali Pharmaceutical Co's PB Ratio of today is 2.38.

Good Sign:

Dali Pharmaceutical Co Ltd stock PB Ratio (=2.58) is close to 10-year low of 2.58

The historical rank and industry rank for Dali Pharmaceutical Co's PB Ratio or its related term are showing as below:

SHSE:603963' s PB Ratio Range Over the Past 10 Years
Min: 2.38   Med: 4.47   Max: 11.66
Current: 2.38

During the past 12 years, Dali Pharmaceutical Co's highest PB Ratio was 11.66. The lowest was 2.38. And the median was 4.47.

SHSE:603963's PB Ratio is ranked worse than
58.46% of 958 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs SHSE:603963: 2.38

During the past 12 months, Dali Pharmaceutical Co's average Book Value Per Share Growth Rate was -5.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -0.80% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Dali Pharmaceutical Co was 18.30% per year. The lowest was -18.10% per year. And the median was -3.40% per year.

Back to Basics: PB Ratio


Dali Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Dali Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co PB Ratio Chart

Dali Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.08 3.64 4.64 7.15 6.85

Dali Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 6.31 6.40 6.85 6.51

Competitive Comparison of Dali Pharmaceutical Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dali Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's PB Ratio falls into.



Dali Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dali Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=4.07/1.71
=2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Dali Pharmaceutical Co  (SHSE:603963) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Dali Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dali Pharmaceutical Co (SHSE:603963) Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Executives
Wu Pei Rong senior management
Yang Jun Xiang Directors, senior managers
Yang Jun Wei Director

Dali Pharmaceutical Co (SHSE:603963) Headlines

No Headlines